Welcome Guest | Register / Login

Schizophrenia Market Research Reports

Sort By
Title Published Price
Schizophrenia-API Insights, 2016
By Delve Insight
The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming ye...
Nov 2016 $ 1250
Cognitive Impairment Associated With Schizophrenia (CIAS)-Pipeline Insights, 2016
By Delve Insight
DelveInsight's, " Cognitive Impairment Associated With Schizophrenia (CIAS)-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Cognitive Impairment Associated With Schizophren...
Nov 2016 $ 1250
Global Schizophrenia Partnering 2010 to 2016
By Current Partnering
"Delivery of this report will take 1-3 days after purchase." The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the...
Nov 2016 $ 1495
Disease and Therapy Review: Schizophrenia
By Timely Data resources
The Schizophrenia Disease and Therapy Review provides an overview of the disease and related conditions, with  incidence and prevalence numbers and percentages for major countries worldwide,  and an overview of treatment.  Dosing an...
Feb 2013 $ 950
Schizophrenia – Pipeline Review, H1 2012
By Global Markets Direct
Schizophrenia – Pipeline Review, H1 2012 Summary Global Markets Direct’s, 'Schizophrenia - Pipeline Review, H1 2012', provides an overview of the Schizophrenia therapeutic pipeline. This report provides informat...
Feb 2012 $ 500
Schizophrenia Global Clinical Trials Review, H2, 2011
By GlobalData
Schizophrenia Global Clinical Trials Review, H2, 2011SummaryGlobalData's clinical trial report, “Schizophrenia Global Clinical Trials Review, H2, 2011" provides data on the Schizophrenia clinical trial scenario. This ...
Oct 2011 $ 1000
Schizophrenia-Pipeline Review,H2 2011
By Global Markets Direct
Report SummaryGlobal Markets Direct’s, 'Schizophrenia - Pipeline Review, H2 2011', provides an overview of the Schizophrenia therapeutic pipeline. This...
Sep 2011 $ 500
Global Schizophrenia Prevalence, Companies Analysis & Drugs Forecast (2010 - 2015)
By Renub Research
Schizophrenia - Market Overview Schizophrenia is a mental disorder characterized by disintegration of thought processes and of emotional responsiveness. It most commonly manifests as auditory hallucinations, paranoid or bi...
Aug 2011 $ 850
Schizophrenia - Pipeline Review, Q1 2011
By Global Markets Direct
Schizophrenia - Pipeline Review, Q1 2011SummaryGlobal Markets Direct’s, 'Schizophrenia - Pipeline Review, Q1 2011', provides an overview of the Schizophrenia therapeutic pipeline. This report provides information on the...
Feb 2011 $ 500
Schizophrenia Global Clinical Trials Review, Q1, 2011
By GlobalData
Report SummaryGlobalData's clinical trial report, “Schizophrenia Global Clinical Trials Review, Q1, 2011 provides data on the Schizophrenia clinical trial scenario. This report provides in-depth information and data re...
Jan 2011 $ 1000